Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
33,251
Value
$2.60M
% of portfolio
1.2%
Quarters held
15
Since Q4 2022
Holdings of HALO by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,251$2.60M1.2%+23,151+229.2%AddedHolders
Q1 202610,100$652.8K0.4%00.0%UnchangedHolders
Q4 202510,100$679.7K0.4%00.0%UnchangedHolders
Q3 202510,100$740.7K0.6%+100+1.0%AddedHolders
Q2 202510,000$520.2K0.5%00.0%UnchangedHolders
Q1 202510,000$638.1K0.6%00.0%UnchangedHolders
Q4 202410,000$478.1K0.4%00.0%UnchangedHolders
Q3 202410,000$572.4K0.5%00.0%UnchangedHolders
Q2 202410,000$523.6K0.5%00.0%UnchangedHolders
Q1 202410,000$406.8K0.3%00.0%UnchangedHolders
Q4 202310,000$369.6K0.3%00.0%UnchangedHolders
Q3 202310,000$382.0K0.3%00.0%UnchangedHolders
Q2 202310,000$360.7K0.3%00.0%UnchangedHolders
Q1 202310,000$382.0K0.3%00.0%UnchangedHolders
Q4 202210,000$569.0K0.4%+10,000NewHolders